News

Application of whole genome sequencing approaches to cancer

Published on: 11 November 2019
Member News, Funding news
Funding
News-3

UK businesses and research organisations can apply for a share of up to £5.4 million. This is for projects involving the application of whole genome sequencing to analyse cancers. This funding is from the Industrial Strategy Challenge Fund.

Description:

Innovate UK, part of UK Research and Innovation, will invest up to £5.4 million. This is for innovation projects that use whole genome sequencing to analyse cancers. This competition is funded through the Industrial Strategy Challenge Fund.

The aim is to encourage the development of new approaches to targeted therapy based on the molecular signatures of cancers. Your project can develop new analytical methods or validate new targets using new and existing genomic data from cancers.

We will fund feasibility studies, industrial research and experimental development.

This competition closes at midday 12pm UK time on the deadline stated.

Funding type:

Grant

Project size:

Feasibility projects must have total eligible costs between £50,000 and £100,000. Industrial research and experimental development projects must have total eligible costs of between £100,000 and £1 million.

Important Dates:

  • Competition opens: Monday 7 October 2019
  • Competition closes: Wednesday 22 January 2020 12:00pm

We've evolved - welcome to Global Health Connector

You’ve been redirected from echalliance.com because ECHAlliance is now Global Health Connector. We are the same network, with the same mission and value, only with a new name that reflects our global reach.